Which pill stops the itch? new study pits methotrexate against apremilast for psoriasis relief
NCT ID NCT07432386
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test whether methotrexate or apremilast works better at reducing itching and improving daily life in 80 adults with psoriasis. Participants will take one of the two oral medications for 8 weeks. The main goal is to see which drug provides more relief from the itch and improves quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pak Emirates Military Hospital
Rawalpindi, Punjab Province, 46000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••